Annual report pursuant to Section 13 and 15(d)

Intangible Assets (Details Textual)

v3.8.0.1
Intangible Assets (Details Textual) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Finite-Lived Intangible Assets [Line Items]    
Amortization of Intangible Assets $ 4,700 $ 3,500
Impairment of Intangible Assets, Finite-lived $ 0 $ 0
MIST Therapy Trade Name [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Asset, Useful Life [1] 3 years 3 years
Impairment of Intangible Assets, Finite-lived [1]   $ 1,688
[1] In December 2016, the Company determined the tradename related to MIST Therapy was no longer an indefinite-lived intangible asset. The Company assigned a remaining useful of approximately 1.5 years, consistent with the Company’s other trademarks.